Related Experiment Video
Updated: Jun 4, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Reassessing cardiovascular risk stratification in men with erectile dysfunction
João Lorigo1, Daniela Gomes2, Ana Rita Ramalho3
1Centro Hospitalar e universitário de Coimbra. joaolorigo@gmail.com.
Insights
Erectile dysfunction (ED) is a key cardiovascular disease (CVD) risk indicator. European Society of Cardiology (ESC) criteria are more sensitive than Princeton Consensus (PC) for identifying high-risk men with ED, aiding crucial CVD prevention.
Area of Science:
- Cardiology
- Urology
- Preventive Medicine
Background:
- Erectile dysfunction (ED) serves as a significant independent predictor of cardiovascular disease (CVD).
- The Princeton Consensus (PC) provides guidelines for assessing CVD risk in men with ED, but European-specific recommendations are lacking.
- Recent updates to the PC criteria focus on American demographics, necessitating European validation.
Purpose of the Study:
- To evaluate and compare the effectiveness of the Princeton Consensus (PC) criteria versus the European Society of Cardiology (ESC) CVD Risk Criteria in stratifying cardiovascular risk in European men presenting with erectile dysfunction.
- To highlight the importance of updated recommendations for accurately identifying men with ED who require further cardiologic assessment.
Main Methods:
- A cross-sectional study involving 137 male patients with ED was conducted.
- Data were collected from hospital registries.
- Two risk stratification models, PC and ESC CVD Risk Criteria, were applied and compared.
Main Results:
- The PC criteria classified 39.7% of patients as "Low Risk," whereas the ESC criteria identified only 12% as "Low Risk" (p < 0.05).
- A significant proportion of patients deemed "Low Risk" by PC were reclassified as "High" (52.5%) or "Very High" (20%) risk by ESC criteria.
- One case of myocardial infarction occurred in a patient initially classified as "Low Risk" by PC but as "High Risk" by ESC criteria.
Conclusions:
- The ESC criteria demonstrate superior sensitivity in detecting CVD risk among men with ED compared to the PC criteria.
- There is a concern that the PC criteria may lead to underestimation of CVD risk, potentially causing urologists to overlook patients with undiagnosed CVD.
- Failure to identify high-risk individuals could result in missed opportunities for preventing major adverse cardiovascular events (MACEs) and premature mortality.
Background And Objectives:
Erectile dysfunction (ED) is an independent and strong marker of cardiovascular disease (CVD) risk. The Princeton Consensus aimed to evaluate and manage cardiovascular risk in men with ED and no known cardiovascular disease, focusing on identifying those requiring additional cardiologic work-up. It has recently been updated to the American population demographics, but European recommendations are needed.
Methods:
It was developed a cross-sectional investigation including erectile dysfunction patients. Data were collected from hospital registries. Two risk stratification models were employed and compared: Princeton Consensus Criteria (PC) and European Society of Cardiology (ESC) CVD Risk Criteria. The objective was to stress the importance of the changes in IV Princeton Consensus recommendations in stratifying CVD risk in men with erectile dysfunction using a model validated in European men.
Results:
A total of 137 patients with ED, with a mean age of 57.1 years old, were included. According to the PC criteria, 39.7% of the patients were "Low Risk". When using ESC criteria, the proportion of "Low Risk" patients were significantly lower (12%, p < 0.05). Among "Low Risk" patients according to the PC, 52.5% and 20% were classified as High and Very high risk according to ESC criteria, respectively. One myocardial infarction was reported. The patient was classified as "Low Risk" according to the PC, but the ESC criteria categorized him as "high risk".
Conclusions:
PC is less sensitive than ESC recommendations detecting CVD. It raises concerns that Urologists could be overlooking patients with undiagnosed CVD, consequently missing out on opportunities for prevention of major cardiovascular events (MACEs) and premature deaths.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...

